Scholay

学术搜索 · AI 审稿 · LaTeX 协作

A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis

作者:Lung‐Yi Mak, Ed Gane, Christian Schwabe, Ki Tae Yoon, Jeong Heo, Russell Scott, Jeong‐Hoon Lee, Jung Il Lee, Young Oh Kweon, Martin Weltman, Stephen A. Harrison, Brent A. Neuschwander‐Tetri, Kenneth Cusi, Rohit Loomba, Bruce D. Given, Dawn R. Christianson, Eric Garcia-Medel, Min Yi, James Hamilton, Man‐Fung Yuen · 发表于:Journal of Hepatology · 年份:2022 · DOI:10.1016/j.jhep.2022.11.025 · 被引用次数:89 · 研究领域:Liver Disease Diagnosis and Treatment、Liver Diseases and Immunity、Hepatitis C virus research